medigraphic.com

2008, Number 2

<< Back Next >>

Med Sur 2008; 15 (2)

Obstructive sleep apnea-hypopnea syndrome (OSAHS)

Flores-Gama C, Flores-Gama F, Bahena-Aponte JA

Language: Spanish
References: 85
Page: 100-111
PDF size: 139.34 Kb.


ABSTRACT

Obstructive sleep apnea-hypopnea syndrome is a more and more prevalent upheaval in the general population characterized by repetitive episodes of total or partial obstruction in some point of the upper airways airway; associated to hypoxemia and to the increasing respiratory effort that produces dream fragmentation, these with important consequences in the patient´s quality life, not only result in diurnal sleepiness, but also increase the cardiovascular morbi-mortality. Although several predictive models have been developed to improve the certainty of the diagnosis on the basis of clinical criteria, to the date the gold standard for the diagnosis and degree of the continuous treatment still being polisomnography. The use of ventilation with positive airway pressure has been very effective when diminishing the number of events of apnea and hypopnea, although sometimes it is a challenge to obtain a suitable attachment to the treatment by the patient.


REFERENCES

  1. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med 2005; 142(3): 187-197.

  2. Olson E, Moore WR, Morgenthaler TI, Gay P, Staats BA. Obstructive sleep apnea- hypopnea syndrome. Mayo Clinic Proc 2003; 78(12): 1545-1552.

  3. Ward F. Obstructive sleep apnea. N Engl J Med 2002; 347(7): 498-504.

  4. Man GCW. Obstructive sleep apnea. Medical Clinics of North America 1996; 80: 803-817.

  5. Hiestand DM, Britz P, Goldman M, Phillips B. Prevalence of symptoms and risk of sleep apnea in the US population: Results from the national sleep foundation sleep in America 2005 poll. Chest 2006; 130(3): 780-786.

  6. Netzer NC, Hoegel JJ, Loube D, Netzer CM, Hay B, Alvarez-Salas R et al. Prevalence of symptoms and risk of sleep apnea in primary care. Chest 2003; 124(4): 1406-1414.

  7. Dancey DR, Hanly PJ, Soong C, Lee B, Hoffstein V. Impact of menopause on the prevalence and severity of sleep apnea. Chest 2001(1); 120: 151-155.

  8. Villaneuva AT, Buchanan PR, Yee BJ, Grunstein RR. Ethnicity and obstructive sleep apnea. Sleep Medicine Reviews 2005; 9(6): 419-436.

  9. Tamarin F, Brandstetter R. Risk for obstructive sleep apnea. Ann Intern Med 2000; 132(9): 758-759.

  10. Malhotra A, Pillar G, Fogel R, Beauregard J, Edwards J, White DP. Upper–Airway collapsibility: Measurements and sleep effects. Chest 2001; 120(1): 156- 161.

  11. Kobayashi I., Perry A, Rhymer B. Inspiratory coactivation of genioglossus enlarges the retroglossal space in laryngectomized humans. J App Physiol 1996; 88: 1594-1604.

  12. Goh DY, Galster P, Marcus C. Sleep architecture and respiratory disturbances in children with obstructive sleep apnea. Am J Respir Crit Care Med 2000; 162(2): 682-686.

  13. Banno K, Kyger M. Sleep apnea: Clinical investigations in humans. Sleep Medicine 2007; (7): 400-426.

  14. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clinic Proc 2004; 79(8): 1036-1046.

  15. Lindberg E, Janson C, Svärdsudd K, Gislason T, Hetta J, Gunnar B. Increased mortality among sleepy snorers: a prospective population based study. Thorax 1998 (8); 53: 631-637.

  16. Remburg S, Launois S, Weiss W. Patients with obstructive sleep apnea have an abnormal peripheral vascular response to hypoxia. J Appl Physiol 1999; 87: 1148-1153.

  17. Sforza E, Boudewijns A, Schnedecker B, Zamagni M, Krieger J. Role of chemosensitivity in intrathoracic pressure changes during obstructive sleep apnea. Am J Respir Crit Care Med 1996; 154(6): 1741-1747.

  18. Imadojemu VA, Mawji Z, Kunselman A, Gray K, Hogeman CS, Leuenberger UA. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest 2007; 131(5): 1406-1413.

  19. Schneider H, Schaub CD, Chen CA, Andreoni KA, Schwartz AR, Smith PL et al. Neural and local effects of hypoxia on cardiovascular responses to obstructive apnea. J Appl Physiol 2000; 88(3): 1093-1102.

  20. Roux F, D´Ambrosio C, Mohsenin V. Sleep–related breathing disorders and cardiovascular disease. Am J Med 2000; 108(5): 396-402.

  21. Lavie P, Herrer P. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ 2000 (7233); 320: 479-482.

  22. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342(19): 1378-1384.

  23. Arabi Y, Morgan BJ, Goodman B, Puleo DS, Xie A, Skatrud JB. Daytime blood pressure elevation after nocturnal hypoxia. J Appl Physiol 1999; 87(2): 689-698.

  24. Holger K, Caidahl K, Samuelsson A, Yüksel P, Hedner J. Impairment of vascular endothelial function and left ventricular filling. Chest 2001; 119(4): 1085-1091.

  25. Coy TV, Dimsdale JE, Ancoli-Israel S, Clausen JL. The Role of Sleep – disordered breathing in essential hypertension. Chest 1993; 109(4): 890-895.

  26. Kuniyoshi, Fatima HS, Somers VK. Sleep apnea in hypertension: When, how, and why should we treat? Hypertension 2006; 47(5): 818-819.

  27. Baguet JP, Narkiewicz K, Mallion JM. Update on hypertension management: Obstructive sleep apnea and hypertension. Journal of Hypertension 2006; 24(1): 205- 210.

  28. Chobain AV, Bakris GL, Black HR. National high blood pressure education program coordinating committee. The seventh report of the national committee in prevention, detection, evaluation and treatment of high blood pressure. JAMA 2003; 289: 2560-2572.

  29. Schafer H, Koehler U, Ploch T, Peter JH. Sleep-Related ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 1997; 111(2): 387-393.

  30. Bradley DT, Hall MJ, Ando S, Floras J. Hemodynamic effects of simulated obstructive apneas in human with and without heart failure. Chest 2001; 119(6): 1827-1835.

  31. Koehler U, Becker HF, Grimm W, Heltmann J, Peter JH, Schafer H. Relations among hypoxemia, sleep stage, and bradyarrhythmia during obstructive sleep apnea. Am Heart Journal 2000; 139(1): 142-148.

  32. Schneider H, Schaub CD, Chen CA, Andreoni KA, Schwartz AR, Smith PL et al. Effects of arousal and sleep state on systemic and pulmonary hemodynamics in obstructive apnea. J Appl Physiol 2000; 88(3): 1084-1092.

  33. Palomaki H, Partinen M, Juvela S, Kaste M. Snoring as a risk factor for sleep-related brain infarction. Stroke 1989; 20(10): 1311-1315.

  34. Yaggi HK, Concato J, Kernnan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353(19): 2034-2041.

  35. Muñoz R, Duran-Cantolla J, Martínez-Vila E, Gallego J, Rubio E, Aizpuru F et al. Severe sleep apnea and risk of ischemic stroke in elderly. Stroke 2006; 37(9): 2317-2321.

  36. Chervin RD. Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. Chest 2000; 118(2): 372-379.

  37. Black JE, Brooks SN, Nishino S. Conditions of primary excessive daytime sleepiness. Neurol Clin 2005; 23: 1025.

  38. Terán-Santos J, Jiménez-Gómez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. N Engl J Med 1999; 340(11): 847-851.

  39. Masa JF, Rubio M, Findley LJ. Habitually sleepy drivers have a high frequency of automobile crashes associated with respiratory disorders during sleep. Am J Respir Crit Care Med 2000; 162(4): 1407-1412.

  40. George CF. Sleep. 5: Driving and automobile crashes in patients with obstructive sleep apnea/hypopnea syndrome. Thorax 2004; 59: 804.

  41. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of metabolic syndrome. Sleep Medicine Reviews 2005; 9: 211-224.

  42. Fisiología del dormir y sus trastornos con énfasis en el insomnio y su tratamiento. Atención Médica (Curso a distancia) Marzo 2001.

  43. Wilson K, Stoohs RA, Mulrooney TF, Johnson LJ, Guilleminault C, Huang Z. The snoring spectrum: assessment of snoring intensity. Chest 1999; 115(3): 762-770.

  44. Pevernagie DA, Stanson A, Sheedy P. Effects of body position on the upper airway of patients with obstructive sleep apnea. Am J Respir Crit Care Med 1995; 152(1): 179-185.

  45. Coleman J. Complications of snoring, upper airway resistance syndrome, and obstructive sleep apnea syndrome in adults. Otolaryngol Clin N Am 1999; 32(2): 224-232.

  46. Alvarado R, Espinosa J, Morales M. Frecuencia de los trastornos del sueño en el área metropolitana de la ciudad de México. Roncopatía y apnea del sueño. Arch Neurocien 1996; 1: 341.

  47. Naseem S, Chaudhary B, Collop N. Attention deficit hyperactivity disorder in adults and obstructive apnea. Chest 2001; 119(1): 294-296.

  48. Johns MW. A new method for measuring daytime sleepiness. The Epworth sleepiness scale. Sleep 1991; 14(6): 540-545.

  49. Chervin RD, Aldrich MS. The Epworth sleepiness scale may not reflect objective measure of sleepiness or sleep apnea. Neurology 1999; 52(1): 125-131.

  50. Topol HI, Brooks LJ. Follow-up in primary snoring in children. J Pediatr 2001; 138(2): 291-293.

  51. Ohayon MM, Li KK, Guilleminault C. Risk factors for sleep bruxism in the general population. Chest 2001; 119(1): 53-61.

  52. McNamara F, Sullivan CE. Obstructive sleep apnea in infants: Symptoms to family history of sudden infant death syndrome, apparent life-threatening events, and obstructive sleep apnea. J Pediatr 2000; 136(3): 318-323.

  53. Katz. Obstructive sleep apnea syndrome may be a significant cause of gastroesophageal reflux disease in older people. J Am Geriatr Soc 1999; 47: 1273-1274.

  54. National commission on sleep disorders research. Wake-up America: a national alert. Washington, DC: Government Printing Office 1993; 1: 1-76.

  55. Hailey D, Tran K, Dales R, Mensinkai S, McGahan L. Recommendations and supporting evidence in guidelines for referral of patients to sleep laboratories. Sleep Medicine Reviews 2006; 10: 287-299.

  56. Jokic R, Klimaszewski A, Crossley M, Sridhar G, Fitzpatrick MF. Positional treatment vs continuous airway pressure in patients with positional obstructive sleep apnea syndrome. Chest 1999; 115(3): 771-781.

  57. Oksenberg A, Khamaysi I, Silverberg DS, Tarasiuk A. Association of body position with severity of apneic events in patients with severe nonpositional obstructive sleep apnea. Chest 2000; 118(4): 1018-1024.

  58. Carole L. Nasal steroids as treatment for obstructive sleep apnea: Don´t throw away the scalpel yet. J Pediatr 2001; 138: 765-767.

  59. Díaz M, Rendón A. Tratamiento médico del síndrome de apnea obstructiva durante el sueño. En: Trastornos del dormir. México: primera edición 2000: 330-347.

  60. Brouillette RT, Manoukian JJ, Ducharme FM, Oudjhane K, Earle LG, Ladan S et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 2001; 138(6): 838-844.

  61. Cistulli P, Gotsopoulos J, Marklund M, Lowe A. Treatment of snoring and obstructive sleep apnea with mandibular repositioning appliances. Sleep Medicine Reviews 2004; 8: 443-457.

  62. Basner R. Continuous positive airway pressure for obstructive sleep apnea. N Engl J Med 2007; 356(17): 1751-1758.

  63. Indications and standards for use of nasal continuous airway pressure (PPCVA) in sleep apnea syndromes. Am J Resp Crit Care Med 1994; 150: 1738-1745.

  64. D´Ambrosio C, Bowman T, Mohsenin V. Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure a prospective study. Chest 1999; 115: 123-129.

  65. Han F, Chen E, Wei H, He Q, Ding D, Strohl KP. Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea syndrome. Chest 2001; 119 (6): 1814-1819.

  66. Harbison J, O’Reilly P, McNicholas WT. Cardiac rhythm disturbances in obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 2000; 118: 591-595.

  67. Santamaria J, Iranzo A, Montserrat JM, de-Pablo J. Persistent sleepiness in CPAP treated obstructive sleep apnea patients: Evaluation and treatment. Sleep Medicine Reviews 2007; 11: 195-207.

  68. d´Ortho, Grillier-Lanoir V, Levy P, Goldenberg F, Corriger E, Harf A et al. Constant vs automatic continuous positive airway pressure therapy: home evaluation. Chest 2000; 118(4): 1010-1017.

  69. Acosta B, DiBenedetto R, Rahimi A, Acosta MF, Cuadra O, Van-Nguyen A et al. Hemodynamic effects of noninvasive bilevel positive airway pressure on patients with chronic congestive heart failure with systolic dysfunction. Chest 2000; 118 (4): 1004-1009.

  70. Randerath WJ, Parys K, Feldmeyer F, Sanner B, Rühle KH. Self-adjusting nasal continuous positive airway pressure therapy based on measurement of impedance: A comparison of two different maximum pressure levels. Chest 1999; 116 (4): 9919.

  71. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous airway pressure vs placebo continuous airway pressure on sleep quality in obstructive sleep apnea. Chest 1999; 116(6): 1545-1549.

  72. Morrison F, Décary A, Petit D, Lavigne G, Malo J, Montplaisir J. Daytime sleepiness and EEG spectral analysis in apneic patients before and after treatment with continuous positive airway pressure. Chest 2001; 119: 45-52.

  73. Bacon JP, Farney RJ, Jensen RL, Walker JM, Cloward TM. Nasal continuous airway pressure devices do not maintain in the set pressure dynamically when tested under simulated clinical conditions. Chest 2000; 118: 1441-1449.

  74. Rakotonanahary D, Pelletier-Fleury N, Gagnadoux F, Fleury B. Predictive factors for the need for symptoms humidification during nasal continuous airway pressure therapy. Chest 2001; 119(2): 460-465.

  75. Martins-De-Araujo MT, Vieira SB, Vasquez EC, Fleury B. Heated humidification of face mask to prevent upper airway dryness during continuous positive airway pressure therapy. Chest 2000; 117(1): 142-147.

  76. Winck JC, Delgado JL, Almeida J, Agostinho-Marques J. Heat or wet it? Nasal Symptoms secondary to the use of continuous positive airway pressure in sleep apnea. Chest 2001; 119(1): 310-312.

  77. Li KK, Riley RW, Guilleminault C. An unreported risk in the use of home continuous positive airway pressure and home nasal ventilation in children: mid-face hypoplasia. Chest 2000; 117(3): 916-918.

  78. Valverde JM, Ramírez A, Villareal E, Salinas A. Evaluación económica del tratamiento con CPAP de la apnea obstructiva del sueño. Revista Salud Pública y Nutrición 2000; 1.

  79. Li K. Surgical therapy for adult obstructive sleep apnea. Sleep Medicine Reviews 2005; 9: 201-209.

  80. Coleman J, Rathfoot MC. Oropharyngeal surgery in the management of upper airway obstruction during sleep. Otolaryngol Clin North Am 1999; 32: 263-274.

  81. Coleman J. Oral and maxillofacial surgery for the management of obstructive sleep apnea. Otolaryngol Clin North Am 1999; 32: 235-241.

  82. Barthel SW, Strome M. Snoring, obstructive sleep apnea and surgery. Med Clin North Am 1999; 83(1): 85-96.

  83. Coleman J, Bick PA. Suspension sutures for the treatment of obstructive sleep apnea and snoring. Otolaryngol Clin North Am 1999; 32(2): 277-285.

  84. Prinsell JR. Maxillomandibular advancement surgery in a site-specific treatment approach for obstructive sleep apnea in 50 consecutive patients. Chest 1999; 116(6): 1519-1529.

  85. Schneider H, O´Hearn D, Leblenc K. High-flow transtracheal insufflation treats obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161: 1869-1876.




2020     |     www.medigraphic.com